{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T09:16:16Z","timestamp":1719998176896},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Pharmaceutical Association, China","award":["2017ZYY036"],"award-info":[{"award-number":["2017ZYY036"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Shexiang Baoxin Pills (SBP) is widely used for the treatment of unstable angina pectoris (UAP) in China. However, the clinical evidence on the efficacy of SBP for the treatment of UAP is not well concluded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Seven electronic databases will be searched for eligible studies: MEDLINE, EMBASE, The Cochrane Library, Wanfang database, Chinese National Knowledge Infrastructure database, VIP database, and Chinese Biological and Medicine database. Data of included studies will be extracted, and quality will be evaluated. Data synthesis will be performed using RevMan software. Subgroup analysis and sensitivity analysis will also be carried out. Publication bias will be evaluated using funnel plot if included studies are sufficient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This systemic review and meta-analysis will provide synthesized result of clinical efficacy of SBP for the treatment of UAP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This systemic review and meta-analysis will provide high-quality evidence on the clinical efficacy of SBP for the treatment of UAP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration:<\/jats:title>\n            <jats:p>PEROSPERO CRD42019124668<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017119","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:00:56Z","timestamp":1568340056000},"page":"e17119","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Shexiang Baoxin Pills for the treatment of unstable angina pectoris"],"prefix":"10.1097","volume":"98","author":[{"given":"Huadong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"454","DOI":"10.21037\/atm.2018.11.10","article-title":"Unstable angina: trends and characteristics associated with length of hospitalization in the face of diminishing frequency-an evidence of a paradigm shift","volume":"6","author":"Malik","year":"2018","journal-title":"Ann Transl Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/eurheartj\/ehw029","article-title":"Consequences of implementing a cardiac troponin assay with improved sensitivity at Swedish coronary care units: an analysis from the SWEDEHEART registry","volume":"37","author":"Eggers","year":"2016","journal-title":"Eur Heart J"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.amjmed.2017.05.037","article-title":"Unstable angina in the era of cardiac troponin assays with improved sensitivity: a clinical dilemma","volume":"130","author":"Eggers","year":"2017","journal-title":"Am J Med"},{"key":"R4-20230914","first-page":"CD004815","article-title":"Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era","author":"Fanning","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ccl.2014.04.010","article-title":"Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction","volume":"32","author":"Basra","year":"2014","journal-title":"Cardiol Clin"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4103\/0366-6999.208242","article-title":"Research of medical expenditure among inpatients with unstable angina pectoris in a single center","volume":"130","author":"Wu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phymed.2018.04.044","article-title":"Efficacy and safety of oral Panax notoginseng saponins for unstable angina patients: a meta-analysis and systematic review","volume":"47","author":"Duan","year":"2018","journal-title":"Phytomedicine"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11655-016-2272-0","article-title":"Danshen injection as adjuvant treatment for unstable angina pectoris: a systematic review and meta-analysis","volume":"23","author":"Wu","year":"2017","journal-title":"Chin J Integr Med"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1002\/ptr.5848","article-title":"Panax notoginseng preparations for unstable angina pectoris: a systematic review and meta-analysis","volume":"31","author":"Song","year":"2017","journal-title":"Phyther Res"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"e5692","DOI":"10.1097\/MD.0000000000005692","article-title":"Salvianolate injection in the treatment of unstable angina pectoris","volume":"95","author":"Zhang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jchromb.2017.03.033","article-title":"Simultaneous quantification of 11 active constituents in Shexiang Baoxin Pill by ultraperformance convergence chromatography combined with tandem mass spectrometry","volume":"1052","author":"Lv","year":"2017","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fphar.2018.01161","article-title":"Shexiang Baoxin Pill, derived from the traditional Chinese medicine, provides protective roles against cardiovascular diseases","volume":"9","author":"Lu","year":"2018","journal-title":"Front Pharmacol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.atherosclerosis.2017.06.012","article-title":"Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization","volume":"263","author":"Huang","year":"2017","journal-title":"Atherosclerosis"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fphar.2017.00404","article-title":"Shexiang Baoxin Pills for coronary heart disease in animal models: preclinical evidence and promoting angiogenesis mechanism","volume":"8","author":"Zhang","year":"2017","journal-title":"Front Pharmacol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"43632","DOI":"10.1038\/srep43632","article-title":"A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases","volume":"7","author":"Fang","year":"2017","journal-title":"Sci Rep"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jep.2016.11.024","article-title":"A Chinese patent medicine, Shexiang Baoxin Pill, for non-ST-elevation acute coronary syndromes: a systematic review","volume":"194","author":"Zhou","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"6949348","DOI":"10.1155\/2018\/6949348","article-title":"Shexiang Baoxin Pills as an adjuvant treatment for chronic heart failure: a system review and meta-analysis","volume":"2018","author":"Dong","year":"2018","journal-title":"Evid Based Complement Altern Med"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"e13965","DOI":"10.1097\/MD.0000000000013580","article-title":"Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: a systematic review and meta-analysis","volume":"97","author":"Wen","year":"2018","journal-title":"Medicine"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Petticrew","year":"2015","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T21:22:38Z","timestamp":1694726558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017119"}},"subtitle":["Protocol of systemic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017119","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}